Rectal CancerNCT06628674
Developing and Testing the Effect of Online Interactive Videos in Improving Low Anterior Resection Syndrome.
A study testing core muscle exercise and pelvic muscle exercise in people with Rectal Cancer, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
Trial summary
This study aims to develop and test the effect of online interactive videos in improving LARS. Read more about this study
- Who is it for?
- Ages 20 years and older
- Conditions the study is for
- Rectal Cancer
- What is being tested?
- core muscle exercise and pelvic muscle exercise
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 110 participants
- Where
- 1 siteTaiwan
- Study dates
- 15 Nov 2024to 31 Jan 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Stage I-III rectal cancer.
- Patients already know their condition.
- Aged 20 years and older.
- Consciously communicate in Mandarin or Taiwanese.
- Agreed with the interview and had signed the permit.
Who cannot join
- Recurrent rectal cancer.
- Stage IV rectal cancer.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Taiwan1 site, 1 recruiting
- Recruiting
Chang Gung Memorial Hospital, Linkou
Taoyuan, 中和區, 333
Yun-Jen Chou, +886958157686, yjchou@mail.cgu.edu.tw
About this study
Official title: Developing and Testing the Effect of Online Interactive Videos in Improving Low Anterior Resection Syndrome, Psychological Distress,and Quality of Life
This study aims to develop and test the effect of online interactive videos in improving LARS.
- Conditions
- Rectal Cancer
- Being tested
- core muscle exercise, pelvic muscle exercise
- Medical subject headings
- Rectal Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
core muscle exerciseBehavioural
Patients in experiment group will do core muscle exercise with online interactive videos
pelvic muscle exerciseBehavioural
Patients in experiment group will do pelvic muscle exercise without online interactive videos
| Study group | Role | What they receive |
|---|---|---|
| Core muscle exercise | Experimental | Not described Receives: Behavioral: core muscle exercise |
| pelvic muscle exercise | Other | Not described Receives: Behavioral: pelvic muscle exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-report Questionnaire
Show the specific trajectory of LAR Syndrome, psychological distress and fecal incontinence-related QoL in patients with rectal cancer
Measured: Change from baseline symptom to 6 months after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2024
- Study start15 Nov 2024
- Primary completion31 Jul 2027 (estimated)
- Study completion31 Jan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Rectal CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 110 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chang Gung Memorial Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06628674
- Sponsor's protocol ID
- 202301931B0
- Status last verified
- Mar 2026
- First submitted
- 4 Oct 2024
- Last updated
- 20 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Developing and Testing the Effect of Online Interactive Videos in Improving Low Anterior Resection Syndrome, Psychological Distress,and Quality of Life
- ClinicalTrials.gov ID
- NCT06628674
- Acronym / sponsor ID
- 202301931B0
- Conditions
- Rectal Cancer
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 110 participants (estimated)
- Lead sponsor
- Chang Gung Memorial HospitalUniversity, hospital or other
- Study start
- 15 Nov 2024 (actual)
- Primary completion
- 31 Jul 2027 (estimated)
- Study completion
- 31 Jan 2028 (estimated)
- First posted
- 8 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to develop and test the effect of online interactive videos in improving LARS.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Core muscle exercise | Experimental | Behavioral: core muscle exercise |
| pelvic muscle exercise | Other | Behavioral: pelvic muscle exercise |
Who may qualify
- Ages
- 20 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Stage I-III rectal cancer.
- Patients already know their condition.
- Aged 20 years and older.
- Consciously communicate in Mandarin or Taiwanese.
- Agreed with the interview and had signed the permit.
Key exclusion criteria (2 listed)
- Recurrent rectal cancer.
- Stage IV rectal cancer.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| core muscle exercisePatients in experiment group will do core muscle exercise with online interactive videos | Behavioural | Core muscle exercise |
| pelvic muscle exercisePatients in experiment group will do pelvic muscle exercise without online interactive videos | Behavioural | pelvic muscle exercise |
Primary outcome
Self-report Questionnaire
Time frame: Change from baseline symptom to 6 months after intervention
Show the specific trajectory of LAR Syndrome, psychological distress and fecal incontinence-related QoL in patients with rectal cancer
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Mar 2026.
Related trials for Rectal Cancer
Active, not recruitingPhase 1/2
A Beta-only IL-2 ImmunoTherapY Study
Advanced Solid Tumor, Unresectable Solid Tumor
RecruitingPhase 1
A Study of MGC030 in Participants With Advanced Solid Tumors
Urothelial Cancer, GastroEsophageal Cancer
Not yet recruitingPhase 2
Exploratory Study of Short-Course Radiotherapy Followed by Adebrelimab Combined With Chemotherapy for Organ Preservation in Locally Advanced Rectal Cancer
Locally Advanced Resectable Rectal Cancer
RecruitingObservational study
ABCSG R07 Rectal Cancer Registry
Rectal Cancer, Adenocarcinoma of Rectum
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing core muscle exercise and pelvic muscle exercise in people with Rectal Cancer, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 20 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Yun-Jen Chou, PhD (+886-3-2118800 ext. 3512, yjchou@mail.cgu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-report Questionnaire (time frame: Change from baseline symptom to 6 months after intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2026.